Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-02-21 | Amended | $360,000,020 | $85,000,020 | Equity Only | 06b | SEC link |
| 2024-02-22 | Amended | $275,000,000 | $100,000,000 | Equity Only | 06b | SEC link |
| 2022-07-14 | New | $175,000,000 | $175,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jorge Bartolome | Director, Executive |
| Daniel Becker | Director |
| Whit Bernard | Executive |
| Paul Berns | Director |
| Michael E. Bozik | Director |
| Stephen Butts | Director |
| Christopher Courts | Executive |
| Christopher Todd Cox | Executive |
| Benjamin Gomez | Director |
| Adam Koppel | Director |
| Ian Read | Director |
| Elyse Stock | Director |
| Chris Visioli | Executive |
| Robin Walker | Executive |